STANDARD BIOTOOLS INC. Quarterly Deferred Income Tax Assets, Net in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Standard Biotools Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q4 2020 to Q4 2023.
  • Standard Biotools Inc. Deferred Income Tax Assets, Net for the quarter ending December 31, 2023 was $135K, a 41.6% decline year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $135K -$96K -41.6% Dec 31, 2023 10-K 2024-03-01
Q4 2022 $231K +$48K +26.2% Dec 31, 2022 10-K 2024-03-01
Q4 2021 $183K -$49K -21.1% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $232K Dec 31, 2020 10-K 2022-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.